CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		93,410,563
Beginning balance at Dec. 31, 2021	$ 158,461	$ 9	$ 187,656	$ (8,983)	$ 0	$ (20,221)
Beginning balance (in shares) at Dec. 31, 2021				(701,305)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(1,087,990)		(1,087,990)
Repurchase of common stock	(13,934)			$ (13,934)
Stock-based compensation	1,605		1,605
Exercise of stock-based awards (in shares)		161,969
Exercise of stock-based awards	38		38
Unrealized (loss) gain on interest rate caplets	4,864				4,864
Net income	15,788					15,788
Ending balance (in shares) at Mar. 31, 2022		92,484,542
Ending balance at Mar. 31, 2022	$ 166,822	$ 9	189,299	$ (22,917)	4,864	(4,433)
Ending balance (in shares) at Mar. 31, 2022				(1,789,295)
Beginning balance (in shares) at Dec. 31, 2022	86,674,390	86,674,390
Beginning balance at Dec. 31, 2022	$ 178,590	$ 9	194,157	$ (81,697)	12,240	53,881
Beginning balance (in shares) at Dec. 31, 2022				(7,829,661)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)	(476,718)	(476,718)		(476,718)
Repurchase of common stock	$ (4,206)			$ (4,206)
Stock-based compensation	1,688		1,688
Exercise of stock-based awards (in shares)		247,153
Exercise of stock-based awards	(602)		(602)
Unrealized (loss) gain on interest rate caplets	(2,166)				(2,166)
Net income	$ 9,182					9,182
Ending balance (in shares) at Mar. 31, 2023	86,444,825	86,444,825
Ending balance at Mar. 31, 2023	$ 182,486	$ 9	$ 195,243	$ (85,903)	$ 10,074	$ 63,063
Ending balance (in shares) at Mar. 31, 2023				(8,306,379)